Kinnate Biopharma Inc.

NASDAQ:KNTE

2.65 (USD) • At close April 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -112.649-116.271-89.763-35.761-11.969-7.63
Depreciation & Amortization 0.7990.6040.1230.08300
Deferred Income Tax -26.58900000
Stock Based Compensation 19.91819.58215.0162.4780.0390.039
Change In Working Capital -3.7046.3691.6243.0141.404-0.611
Accounts Receivables 0000.973-0.0490
Inventory 000-0.97300
Accounts Payables -5.0734.1954.6775.3591.4780
Other Working Capital 1.3692.174-3.053-2.345-0.025-0.611
Other Non Cash Items 22.1820.6821.9350.005-1.390
Operating Cash Flow -100.043-89.034-71.065-30.181-10.526-8.202
Investing Activities:
Investments In Property Plant And Equipment 0-2.719-0.769-0.29700
Acquisitions Net -9.1330.00434.853000
Purchases Of Investments -154.719-176.528-247.142-31.41200
Sales Maturities Of Investments 264.588172.41767.337000
Other Investing Activites 0-0.004-34.853-0.03100
Investing Cash Flow 100.736-6.83-180.574-31.70900
Financing Activities:
Debt Repayment 000000
Common Stock Issued 1.32500253.31479.980
Common Stock Repurchased 000-0.01700
Dividends Paid 000000
Other Financing Activities -7.8081.1636.237350.89979.9815.201
Financing Cash Flow 1.3250.0010.036350.89979.9815.201
Other Information:
Effect Of Forex Changes On Cash -0.0060.0010000
Net Change In Cash 2.012-94.703-215.402289.00969.4546.999
Cash At End Of Period 56.99855.357150.06365.46276.4536.999